AI and Autonomy New Lyme test detects disease early with 90% accuracy It uses a machine-learning algorithm to analyze the immune response, detecting patterns unique to each individual Joseph Morton17 hours ago
Medical and Pharmaceutical Hong Kong lung cancer survivor advocates for AI-powered screening measures Artificial intelligence has the power to cut healthcare costs associated with lung cancer screening in half, he highlighted Rowan Dunne2 days ago
Medical and Pharmaceutical bioAffinity Technologies obtains Canadian patent for lung cancer spit test The CyPath Lung screening tool is also patented in China, Australia and Japan Rowan DunneJuly 22, 2025
Medical and Pharmaceutical Medpace Holdings stock just popped by 50%, but why? Medpace delivered a standout Q2, with revenue rising 14.2 per cent year-over-year to USD$603.3 million Joseph MortonJuly 22, 2025
Medical and Pharmaceutical American researcher anticipates robust growth for e-nose market Market.US is one of multiple that believe the breath analysis industry will be expanding significantly Rowan DunneJuly 17, 2025
Medical and Pharmaceutical Cizzle Bio submits NIH grant proposal for biomarker blood test for lung cancer The study will analyze pre-diagnostic and longitudinal blood plasma samples from the PLCO Cancer Screening Trial Joseph MortonJuly 14, 2025
AI and Autonomy SimBioSys gets FDA nod for AI breast cancer platform The platform's latest update represents the next evolution of a clinically validated platform designed to improve consistency, precision, and efficiency Joseph MortonJuly 10, 2025
AI and Autonomy New artificial intelligence tech allows for digital mapping of tumours iSeg uses 3D imagery to provide a deeper understanding of tumours Joseph MortonJuly 7, 2025
AI and Autonomy The dual nature of artificial intelligence: A Mugglehead roundup AI is not inherently good or bad—it is a tool, shaped by how we choose to use it Joseph MortonJune 20, 2025
Medical and Pharmaceutical Breathe BioMedical adds research site to breast cancer breath test study The Canadian company aims to provide an accurate screening measure for women with dense breast tissue Rowan DunneJune 18, 2025